Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M
Medizinische Klinik Innenstadt, Ludwig-Maximilian University, Munich, Germany.
Eur J Endocrinol. 2009 Mar;160(3):443-51. doi: 10.1530/EJE-08-0711. Epub 2009 Jan 8.
The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.
Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.
All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.
We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible.
通过分子和临床研究,调查G蛋白偶联受体在原发性醛固酮增多症(PA)中的表达及其功能相关性。
选取14个醛固酮瘤(APA)组织、1个单侧肾上腺增生组织以及6个健康成人肾上腺组织;12例确诊为APA所致PA的患者(n = 5)、特发性醛固酮增多症患者(n = 7)以及8名对照者(C)。对这些组织进行定量PCR,以测定AT2R1、GIPR、MC2R、GnRHR、LHR、TRHR、TSHR、胰高血糖素受体、V1aR、V2R和5-HT4R的mRNA表达水平。患者和对照者参与了一项测试方案,该方案包括体位刺激、混合餐、促肾上腺皮质激素(ACTH)、促性腺激素释放激素(GnRH)、促甲状腺激素释放激素(TRH)、胰高血糖素、血管加压素和甲氧氯普胺(MCP)刺激。3例患者可通过两项研究进行分析。阳性反应定义为刺激后醛固酮增加超过50%。
所有组织均显示AT2R1、MC2R、精氨酸血管加压素受体(AVPR)和5-HT4R mRNA表达。在正常肾上腺和13个肾上腺肿瘤中发现了LHR mRNA。与正常肾上腺相比,肿瘤性肾上腺组织表达GnRHR mRNA(4/15)和TSHR mRNA(1/15)。患者和对照者对体位、ACTH、胰高血糖素、血管加压素和MCP均有反应。1例患者在TRH刺激后出现特异性反应,3例患者在GnRH刺激后出现特异性反应。
我们提供了证据,证明PA患者对包括GnRH和TRH在内的各种肽类激素有肽类激素反应性。临床检测与分子检测之间存在良好的相关性,这使得PA中表达的受体可能参与其中。